Intellectual Property


Michael Vongaramvilai is an associate in the Firm’s Boston office in the Intellectual Property Practice Group.

Michael has experience working on a wide range of intellectual property matters, including preparing and prosecuting US and international patent applications, patent litigation and technology transactions. Michael's technical background is in molecular toxicology and his experience covers a broad range of applications, including medical devices and therapeutics.

Prior to joining Brown Rudnick, Michael was an associate at Baker Botts LLP. In this position, Michael drafted and conducted due diligence related to domestic and worldwide agreements and patent licenses for pharmaceutical and biotechnology clients. Michael also assisted with two International Trade Commission (ITC) disputes relating to next-generation sequencing technology.


University of California, Irvine School of Law – J.D., 2014
University of California, Berkeley – B.S., 2009

Bar Admissions

US District Courts, Western District of Texas
US District Courts, Eastern District of Texas
Texas only
US Patent and Trademark Office
“Does Your Final Written Decision Permit “Meaningful Appellate Review”?“ Baker Botts, April 1, 2016
“A Good-Faith Belief of Invalidity Is Not a Defense to Induced Infringement,” V&E IP Insights, May 27, 2015
“Biologics Price Competition and Innovation Act - "Patent Dance" Procedure,” V&E IP Insights, March 27, 2015
Co-author, “Mass Customization — Brought To You By 3-D Printing,” Law360, January 7, 2015
Professional Affiliations
Austin Intellectual Property Law Association (AIPLA), Awards Committee Member
Texas Medical Device Alliance (TMDA), Member